ZA94186B - Agents for vascular diseases - Google Patents

Agents for vascular diseases

Info

Publication number
ZA94186B
ZA94186B ZA94186A ZA94186A ZA94186B ZA 94186 B ZA94186 B ZA 94186B ZA 94186 A ZA94186 A ZA 94186A ZA 94186 A ZA94186 A ZA 94186A ZA 94186 B ZA94186 B ZA 94186B
Authority
ZA
South Africa
Prior art keywords
endothelin
endothelins
analogues
derivatives
partial sequences
Prior art date
Application number
ZA94186A
Other languages
English (en)
Inventor
Ludger Dr Dinkelborg
Sebastian Dr Erber
Christoph Stephan Dr Hilger
Wolfgang Dr Kramp
Hans-Martin Dr Schier
Ulrich Prof Dr Speck
Heinz Dr Gries
Johannes Dr Patzek
H Joseph Reiser
Original Assignee
Diagnostikforschung Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostikforschung Inst filed Critical Diagnostikforschung Inst
Publication of ZA94186B publication Critical patent/ZA94186B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
ZA94186A 1993-01-13 1994-01-12 Agents for vascular diseases ZA94186B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4301871A DE4301871A1 (de) 1993-01-13 1993-01-13 Neue Mittel zur Diagnose von Gefäßerkrankungen

Publications (1)

Publication Number Publication Date
ZA94186B true ZA94186B (en) 1994-08-18

Family

ID=6478840

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94186A ZA94186B (en) 1993-01-13 1994-01-12 Agents for vascular diseases

Country Status (9)

Country Link
EP (1) EP0606683B1 (fr)
JP (1) JP3558169B2 (fr)
KR (1) KR100330794B1 (fr)
AT (1) ATE230416T1 (fr)
AU (1) AU666059B2 (fr)
CA (1) CA2113245A1 (fr)
DE (2) DE4301871A1 (fr)
IL (1) IL108322A (fr)
ZA (1) ZA94186B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425778A1 (de) * 1994-07-13 1996-01-18 Diagnostikforschung Inst Komplexverbindungen zur Diagnose von Gefäßerkrankungen
DE4428851C2 (de) * 1994-08-04 2000-05-04 Diagnostikforschung Inst Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie
DE19536783A1 (de) * 1995-09-21 1997-03-27 Diagnostikforschung Inst Bifunktionelle Nicotinamid-Chelatbildner vom Typ N¶2¶S¶2¶ für radioaktive Isotope
DE19652374A1 (de) * 1996-12-04 1998-06-10 Schering Ag Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
ES2206689T3 (es) * 1996-10-28 2004-05-16 Amersham Health As Agentes de contraste.
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
EP1068224B1 (fr) 1998-03-31 2005-05-11 Bristol-Myers Squibb Pharma Company Produits pharmaceutiques pour l'imagerie de troubles angiogenes
US6524553B2 (en) 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6511649B1 (en) 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
EP1140204A2 (fr) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Medicaments antagonistes du recepteur de la vitronectine
CA2349333A1 (fr) 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company Medicaments antagonistes du recepteur de la vitronectine
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
KR100675356B1 (ko) * 2005-04-29 2007-02-01 경희대학교 산학협력단 액체 또는 초임계상태의 유체를 이용하여 금속이온 및금속산화물을 추출하는 금속추출에 사용되는 신규한 아미드화합물을 포함하는 킬레이트제와 상기 킬레이트제를이용한 금속추출방법 및 금속추출시스템
GB0513812D0 (en) 2005-07-05 2005-08-10 Isis Innovation Compounds for imaging and therapy
EP2345974B1 (fr) 2006-06-28 2014-08-06 IHI Corporation Composé ciblable magnétiquement
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
JP2009274962A (ja) * 2008-05-12 2009-11-26 Yoshihiro Ishikawa 鉄サレン錯体、磁性を有する薬剤、薬剤の誘導システム、並びに磁気検出装置
CN104800195A (zh) 2008-11-20 2015-07-29 株式会社Ihi 自磁性金属salen络合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE66469T1 (de) * 1985-01-14 1991-09-15 Neorx Corp Metall-radionuklid markiertes protein fuer diagnose und therapie.
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
GB8913089D0 (en) * 1989-06-07 1989-07-26 Ciba Geigy Japan Ltd Novel endothelin derivative
WO1991013089A1 (fr) * 1990-02-26 1991-09-05 Takeda Chemical Industries, Ltd. Derives de peptides et production de ces derives
JPH05507276A (ja) * 1990-05-03 1993-10-21 ニュー・イングランド・ディーコネス・ホスピタル・コーポレイション 動脈造影用合成ペプチド類
CA2127284C (fr) * 1992-01-03 2002-02-05 Buck A. Rhodes Applications pharmaceutiques a base de proteines et de peptides comportant un ion metallique

Also Published As

Publication number Publication date
AU666059B2 (en) 1996-01-25
ATE230416T1 (de) 2003-01-15
EP0606683B1 (fr) 2003-01-02
KR100330794B1 (ko) 2002-07-27
KR940018398A (ko) 1994-08-16
JPH07149799A (ja) 1995-06-13
IL108322A (en) 2001-05-20
EP0606683A3 (fr) 1995-12-27
EP0606683A2 (fr) 1994-07-20
CA2113245A1 (fr) 1994-07-14
DE4301871A1 (de) 1994-07-14
DE59310320D1 (de) 2003-02-06
JP3558169B2 (ja) 2004-08-25
IL108322A0 (en) 1994-04-12
AU5314694A (en) 1994-07-21

Similar Documents

Publication Publication Date Title
ZA94186B (en) Agents for vascular diseases
DE60043197D1 (fr)
IL145830A (en) Glucagon-like peptide-1 compositions for use in treating myocardial tissue injury
GB9006977D0 (en) Compositions
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
IL133585A0 (en) Soluble prodrugs of paclitaxel
UA32577C2 (uk) Радіомічена сполука для утворення зображення тромбів при радіонуклідній діагностиці, радіофармацевтичний препарат та радіофармацевтична композиція на їх основі та комплект для приготування радіофармацевтичних препаратів
EP0458079A3 (en) Ultrasonic contrast agent, its preparation and application as diagnostic or therapeutic
MY104535A (en) Oral composition for the treatment of inflammatory bowel diseases.
RU92004368A (ru) Замещенные пиримидины, способ их получения, фармацевтическая композиция
AU9245601A (en) Peptide-based compounds
DK582789A (da) Knoglemarvundertrykkende middel
NZ235499A (en) Radiolabelled hirudin analogues, pharmaceutical compositions and in vitro and in vivo detection of thrombin
YU33203A (sh) Radioaktivna farmaceutska sredstva za dijagnostikovanje alchajmerove bolesti
BG105302A (en) Means for improving cognition
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
GB2285219A (en) Use of norastemizole for the treatment of allergic disorders
UA26973A1 (uk) Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів
EP1545479A4 (fr) Compositions d'ezetimibe, et procedes pour le traitement de tumeurs benignes et malignes associees au cholesterol
HU902004D0 (en) New trombolitic preparations
EP0626866A4 (en) The use of carotenoporphyrins as tumor localizing agents for diagnosis, visualization and delivery of sensitizers to tumor tissues.
GB9509888D0 (en) Terpenoidic derivatives useful as antitumour agents
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
WO2001040465A3 (fr) Compositions et procedes de traitement de maladies d'ordre immunologique
WO2001080906A3 (fr) Complexes radiometalliques de 2-pyrrolylthiones et leur utilisation comme agents radiopharmaceutiques d'imagerie et de therapie